135 related articles for article (PubMed ID: 11896543)
1. Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5'-nucleotidase mRNA measurement in cell lines and in patients with leukemia.
Månsson E; Liliemark E; Söderhäll S; Gustafsson G; Eriksson S; Albertioni F
Leukemia; 2002 Mar; 16(3):386-92. PubMed ID: 11896543
[TBL] [Abstract][Full Text] [Related]
2. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.
Lotfi K; Karlsson K; Fyrberg A; Juliusson G; Jonsson V; Peterson C; Eriksson S; Albertioni F
Biochem Pharmacol; 2006 Mar; 71(6):882-90. PubMed ID: 16436271
[TBL] [Abstract][Full Text] [Related]
3. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
[TBL] [Abstract][Full Text] [Related]
4. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
[TBL] [Abstract][Full Text] [Related]
5. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity.
Lotfi K; Månsson E; Peterson C; Eriksson S; Albertioni F
Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684
[TBL] [Abstract][Full Text] [Related]
6. RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells.
Fyrberg A; Albertioni F; Lotfi K
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):712-9. PubMed ID: 18600530
[TBL] [Abstract][Full Text] [Related]
7. Expression of deoxynucleoside kinases and 5'-nucleotidases in mouse tissues: implications for mitochondrial toxicity.
Rylova SN; Mirzaee S; Albertioni F; Eriksson S
Biochem Pharmacol; 2007 Jun; 74(1):169-75. PubMed ID: 17493587
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
[TBL] [Abstract][Full Text] [Related]
9. Deoxycytidine kinase and deoxyguanosine kinase of Lactobacillus acidophilus R-26 are colinear products of a single gene.
Ma N; Ikeda S; Guo S; Fieno A; Park I; Grimme S; Ikeda T; Ives DH
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14385-90. PubMed ID: 8962060
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes.
Fyrberg A; Albertioni F; Lotfi K
Biochem Biophys Res Commun; 2007 Jun; 357(4):847-53. PubMed ID: 17459340
[TBL] [Abstract][Full Text] [Related]
11. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.
Galmarini CM; Thomas X; Graham K; El Jafaari A; Cros E; Jordheim L; Mackey JR; Dumontet C
Br J Haematol; 2003 Jul; 122(1):53-60. PubMed ID: 12823345
[TBL] [Abstract][Full Text] [Related]
12. Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR; in relation to enzyme activity.
Sigmond J; Loves WJ; Kroep JR; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1347-50. PubMed ID: 15571256
[TBL] [Abstract][Full Text] [Related]
13. Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia.
Kakihara T; Fukuda T; Tanaka A; Emura I; Kishi K; Asami K; Uchiyama M
Leuk Lymphoma; 1998 Oct; 31(3-4):405-9. PubMed ID: 9869205
[TBL] [Abstract][Full Text] [Related]
14. Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA.
Curbo S; Johansson M; Balzarini J; Lewis LD; Karlsson A
Exp Cell Res; 2009 Sep; 315(15):2539-43. PubMed ID: 19481540
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside.
Flasshove M; Strumberg D; Ayscue L; Mitchell BS; Tirier C; Heit W; Seeber S; Schütte J
Leukemia; 1994 May; 8(5):780-5. PubMed ID: 7514246
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome.
Suzuki K; Sugawara T; Oyake T; Uchiyama T; Aoki Y; Tsukushi Y; Onodera S; Ito S; Murai K; Ishida Y
Leuk Res; 2007 Oct; 31(10):1343-9. PubMed ID: 17350683
[TBL] [Abstract][Full Text] [Related]
17. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
18. Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene.
Owens JK; Shewach DS; Ullman B; Mitchell BS
Cancer Res; 1992 May; 52(9):2389-93. PubMed ID: 1568208
[TBL] [Abstract][Full Text] [Related]
19. Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs.
Rylova SN; Albertioni F; Flygh G; Eriksson S
Biochem Pharmacol; 2005 Mar; 69(6):951-60. PubMed ID: 15748706
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
Xie XT; Jiang SY; Li BS; Yang LL
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]